(414951, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414952, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414953, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014254', 'increased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414954, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414955, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414956, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414957, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414958, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003474', 'abnormal summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414959, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414960, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414961, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414962, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414963, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414964, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414965, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414966, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003465', 'increased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414967, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414968, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414969, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414970, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414971, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414972, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414973, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003990', 'decreased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414974, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414975, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414976, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414977, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414978, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009967', 'abnormal neuron proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414979, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414980, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414981, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414982, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414983, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002826', 'tonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414984, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414985, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414986, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414987, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414988, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021001', 'impaired neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414989, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414990, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414991, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414992, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414993, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414994, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414995, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414996, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(414997, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414998, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(414999, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415000, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415001, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415002, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415003, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415004, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002917', 'decreased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415005, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415006, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415007, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415008, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000951', 'sporadic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415009, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415010, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003470', 'abnormal summary potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415011, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003472', 'increased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415012, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415013, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415014, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415015, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415016, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415017, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003463', 'abnormal single cell response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415018, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415019, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415020, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415021, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415022, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003484', 'abnormal channel response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415023, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415024, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415025, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415026, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415027, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415028, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415029, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415030, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415031, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415032, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415033, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415034, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415035, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415036, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415037, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415038, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415039, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006060', 'increased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415040, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415041, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415042, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415043, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415044, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415045, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415046, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415047, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415048, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415049, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415050, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415051, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003469', 'decreased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415052, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415053, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003996', 'clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415054, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415055, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004811', 'abnormal neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415056, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415057, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415058, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415059, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415060, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415061, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415062, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003477', 'abnormal nerve fiber response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415063, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415064, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415065, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415066, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415067, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415068, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006082', 'CNS inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415069, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415070, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003473', 'decreased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415071, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415072, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003633', 'abnormal nervous system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415073, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415074, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415075, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415076, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415077, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003217', 'increased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415078, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415079, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415080, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415081, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415082, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415083, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415084, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415085, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415086, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013438', 'dysmyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415087, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415088, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415089, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415090, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415091, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415092, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415093, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415094, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415095, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005402', 'abnormal action potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415096, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009141', 'increased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415097, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415098, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415099, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415100, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415101, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415102, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0030990', 'nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415103, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415104, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415105, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415106, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415107, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415108, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415109, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001473', 'reduced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415110, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011397', 'endoneurial edema', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415111, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415112, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001898', 'abnormal long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415113, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415114, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004768', 'abnormal axonal transport', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415115, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415116, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415117, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415118, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415119, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415120, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415121, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415122, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415123, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415124, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415125, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415126, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415127, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415128, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415129, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415130, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415131, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415132, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415133, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415134, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415135, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415136, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415137, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415138, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415139, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415140, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415141, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415142, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014178', 'increased brain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415143, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415144, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415145, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002923', 'increased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415146, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415147, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021009', 'abnormal synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415148, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415149, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415150, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415151, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415152, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415153, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415154, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415155, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415156, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415157, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415158, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003488', 'decreased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415159, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415160, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415161, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415162, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415163, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415164, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415165, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003219', 'increased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415166, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415167, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415168, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415169, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000921', 'demyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415170, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415171, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415172, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415173, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415174, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415175, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415176, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415177, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003486', 'abnormal channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415178, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415179, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415180, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415181, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415182, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415183, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415184, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415185, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415186, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415187, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415188, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415189, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415190, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415191, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415192, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415193, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415194, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415195, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415196, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415197, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415198, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415199, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415200, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415201, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415202, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004495', 'decreased synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415203, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415204, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415205, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415206, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415207, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415208, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415209, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415210, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415211, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415212, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415213, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415214, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415215, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001475', 'reduced long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415216, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415217, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415218, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415219, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415220, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415221, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415222, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415223, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415224, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415225, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415226, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415227, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415228, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415229, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415230, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415231, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000948', 'nonconvulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415232, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415233, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415234, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415235, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415236, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415237, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415238, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415239, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415240, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415241, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415242, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415243, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003889', 'enhanced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415244, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415245, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415246, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415247, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415248, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415249, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415250, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415251, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415252, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415253, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415254, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415255, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415256, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415257, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000920', 'abnormal myelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415258, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415259, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415260, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415261, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415262, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415263, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415264, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415265, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415266, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415267, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415268, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0009142', 'decreased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415269, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415270, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415271, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415272, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415273, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415274, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415275, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415276, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415277, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415278, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415279, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0010050', 'hypermyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415280, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415281, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002193', 'minimal clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415282, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415283, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415284, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0014179', 'abnormal blood-retina barrier function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415285, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415286, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415287, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415288, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415289, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415290, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415291, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415292, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415293, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002916', 'increased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415294, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415295, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013182', 'increased spinal cord apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415296, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415297, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0006058', 'decreased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415298, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415299, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415300, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415301, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(415302, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415303, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415304, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415305, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415306, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415307, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415308, 'HP:0012659', 'Prefrontal hypometabolism in FDG PET', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415309, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415310, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415311, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415312, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415313, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415314, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415315, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415316, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415317, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415318, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415319, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415320, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415321, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415322, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415323, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415324, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415325, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415326, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415327, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415328, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415329, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415330, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415331, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415332, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415333, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415334, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415335, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415336, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415337, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415338, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415339, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415340, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415341, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415342, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415343, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415344, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415345, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415346, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415347, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415348, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415349, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415350, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415351, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415352, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415353, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415354, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415355, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415356, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415357, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415358, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415359, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415360, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415361, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415362, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415363, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415364, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415365, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415366, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415367, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415368, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415369, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415370, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415371, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415372, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415373, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415374, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415375, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415376, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415377, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415378, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415379, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415380, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415381, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415382, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415383, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415384, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415385, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415386, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415387, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415388, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415389, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415390, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415391, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415392, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415393, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415394, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415395, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415396, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415397, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415398, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415399, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415400, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415401, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415402, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415403, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415404, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415405, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415406, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415407, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415408, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415409, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415410, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415411, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415412, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415413, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415414, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415415, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415416, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415417, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415418, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415419, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415420, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415421, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415422, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415423, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415424, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415425, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415426, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415427, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415428, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415429, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415430, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415431, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415432, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415433, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415434, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415435, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415436, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415437, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415438, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415439, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415440, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415441, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415442, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415443, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415444, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415445, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415446, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415447, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415448, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415449, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415450, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415451, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415452, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415453, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415454, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415455, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415456, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415457, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415458, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415459, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415460, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415461, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415462, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415463, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415464, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415465, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415466, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415467, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415468, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415469, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415470, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415471, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415472, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415473, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415474, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415475, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415476, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415477, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415478, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415479, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415480, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415481, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415482, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415483, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415484, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415485, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415486, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415487, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415488, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415489, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415490, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415491, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415492, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415493, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415494, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415495, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415496, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415497, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415498, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415499, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415500, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415501, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415502, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415503, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415504, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415505, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415506, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415507, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415508, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415509, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415510, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415511, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415512, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415513, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415514, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415515, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415516, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415517, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415518, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415519, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415520, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415521, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415522, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415523, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415524, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415525, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415526, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415527, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415528, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415529, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415530, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415531, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415532, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415533, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415534, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415535, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415536, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415537, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415538, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415539, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415540, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415541, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415542, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415543, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415544, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415545, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415546, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415547, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415548, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415549, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415550, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415551, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415552, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415553, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415554, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415555, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415556, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415557, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415558, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415559, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415560, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415561, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415562, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415563, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415564, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415565, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415566, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415567, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415568, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415569, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415570, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415571, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415572, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415573, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415574, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415575, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415576, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415577, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415578, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415579, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415580, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415581, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415582, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415583, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415584, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415585, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415586, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415587, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415588, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415589, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415590, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415591, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415592, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415593, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415594, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415595, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415596, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415597, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415598, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415599, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415600, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415601, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415602, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415603, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415604, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415605, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415606, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415607, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415608, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415609, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415610, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415611, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415612, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415613, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415614, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415615, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415616, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415617, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415618, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415619, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415620, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415621, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415622, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415623, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415624, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415625, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415626, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415627, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415628, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415629, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415630, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415631, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415632, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415633, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415634, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415635, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415636, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415637, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415638, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415639, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415640, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415641, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415642, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415643, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415644, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415645, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415646, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415647, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415648, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415649, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415650, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415651, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415652, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415653, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415654, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415655, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415656, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415657, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415658, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415659, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415660, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415661, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415662, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415663, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415664, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415665, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415666, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415667, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415668, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415669, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415670, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415671, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415672, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415673, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415674, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415675, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415676, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415677, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415678, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415679, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415680, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415681, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415682, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415683, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415684, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415685, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415686, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415687, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415688, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415689, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415690, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415691, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415692, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415693, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415694, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415695, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415696, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415697, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415698, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415699, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415700, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415701, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415702, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415703, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415704, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415705, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415706, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415707, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415708, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415709, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415710, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415711, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415712, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415713, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415714, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415715, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415716, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415717, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415718, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415719, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415720, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415721, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415722, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415723, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415724, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415725, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415726, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415727, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415728, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415729, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415730, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415731, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415732, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415733, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415734, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415735, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415736, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415737, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415738, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415739, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415740, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415741, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415742, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415743, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415744, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415745, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415746, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415747, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415748, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415749, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415750, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415751, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415752, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415753, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415754, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415755, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415756, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415757, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415758, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415759, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415760, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415761, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415762, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415763, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415764, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415765, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415766, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415767, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415768, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415769, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415770, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415771, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415772, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415773, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415774, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415775, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415776, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415777, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415778, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415779, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415780, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415781, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415782, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415783, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415784, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415785, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415786, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415787, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415788, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415789, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415790, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415791, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415792, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415793, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415794, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415795, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415796, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415797, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415798, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415799, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415800, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415801, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415802, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415803, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415804, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415805, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415806, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415807, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415808, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415809, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415810, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415811, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415812, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415813, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415814, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415815, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415816, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415817, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415818, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415819, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415820, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415821, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415822, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415823, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415824, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415825, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415826, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415827, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415828, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415829, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415830, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415831, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415832, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415833, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415834, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415835, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415836, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415837, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415838, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415839, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415840, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415841, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415842, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415843, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415844, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415845, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415846, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415847, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415848, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415849, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415850, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415851, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415852, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415853, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415854, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415855, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415856, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415857, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415858, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(415859, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415860, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415861, 'HP:0034141', 'Anti-SUMO-activating enzyme subunit 2 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(415862, 'HP:0010187', 'Bullet-shaped distal toe phalanx', 'MP:0030791', 'club-shaped femur', 0.4044943820224719, 9.622254160301484, 1.9728526934959711, 'UPHENO:0082444', '3-D shape anatomical entity in independent continuant'),
(415863, 'HP:0011478', 'True anophthalmia', 'MP:0001341', 'absent eyelids', 0.4406779661016949, 9.48475063655155, 2.0444365041490755, 'UPHENO:0025985', 'absent anatomical entity in the face'),
(415864, 'HP:0011478', 'True anophthalmia', 'MP:0002697', 'abnormal eye size', 0.40350877192982454, 8.581084971325078, 1.8607909766023845, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(415865, 'HP:0011478', 'True anophthalmia', 'MP:0010710', 'absent sclera', 0.4576271186440678, 9.48475063655155, 2.0833816512733745, 'UPHENO:0025985', 'absent anatomical entity in the face'),
(415866, 'HP:0011478', 'True anophthalmia', 'MP:0013929', 'absent eye muscles', 0.4126984126984127, 9.48475063655155, 1.9784694924474027, 'UPHENO:0025985', 'absent anatomical entity in the face'),
(415867, 'HP:0011478', 'True anophthalmia', 'MP:0003078', 'aphakia', 0.43548387096774194, 9.48475063655155, 2.032352312560306, 'UPHENO:0025985', 'absent anatomical entity in the face'),
(415868, 'HP:0011478', 'True anophthalmia', 'MP:0010709', 'absent eye anterior chamber', 0.43548387096774194, 9.48475063655155, 2.032352312560306, 'UPHENO:0025985', 'absent anatomical entity in the face'),
(415869, 'HP:0011478', 'True anophthalmia', 'MP:0001293', 'anophthalmia', 0.5, 16.19210976863243, 2.8453567235614265, 'UPHENO:0009368', 'absent eyeball of camera-type eye'),
(415870, 'HP:0011478', 'True anophthalmia', 'MP:0005242', 'cryptophthalmos', 0.40625, 9.48475063655155, 1.9629518450790042, 'UPHENO:0025985', 'absent anatomical entity in the face'),
(415871, 'HP:0011478', 'True anophthalmia', 'MP:0012247', 'absent cornea', 0.4090909090909091, 9.48475063655155, 1.9698033557711927, 'UPHENO:0025985', 'absent anatomical entity in the face'),
(415872, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0003298', 'choking', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415873, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0011043', 'abnormal lung elastance', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415874, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010993', 'decreased surfactant secretion', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415875, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010936', 'decreased airway resistance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415876, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001950', 'abnormal respiratory sounds', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415877, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002133', 'abnormal respiratory system physiology', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415878, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0011046', 'abnormal lung tissue damping', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415879, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010334', 'pleural effusion', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415880, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0031105', 'rhonchi', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415881, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415882, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002327', 'abnormal respiratory function', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415883, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0031102', 'rhinorrhea', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415884, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002306', 'abnormal functional residual capacity', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415885, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0012124', 'increased bronchoconstrictive response', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415886, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010950', 'abnormal lung hysteresivity', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415887, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001943', 'abnormal respiration', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415888, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(415889, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002335', 'decreased airway responsiveness', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415890, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014029', 'increased respiratory epithelial chloride transmembrane transport', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415891, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0013752', 'stridor', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415892, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010753', 'improved mucociliary clearance', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415893, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002322', 'abnormal respiratory transport', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415894, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0031088', 'coughing', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415895, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001958', 'emphysema', 0.42105263157894735, 8.526773851447254, 1.8947877371965502, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415896, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0031089', 'sneezing', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415897, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002314', 'abnormal respiratory mechanics', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415898, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014274', 'decreased respiration', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415899, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415900, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0031098', 'abnormal sputum production', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415901, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002333', 'abnormal lung compliance', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415902, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010822', 'pneumothorax', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415903, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002296', 'aspiration', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415904, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0005575', 'increased pulmonary ventilation', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415905, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415906, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415907, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0031104', 'crackles', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415908, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0004781', 'abnormal surfactant composition', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415909, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002334', 'abnormal airway responsiveness', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415910, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415911, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010895', 'increased lung compliance', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415912, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415913, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415914, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0005585', 'increased tidal volume', 0.45, 8.526773851447254, 1.9588384908284973, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415915, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0011045', 'decreased lung elastance', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415916, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0005586', 'decreased tidal volume', 0.45, 8.526773851447254, 1.9588384908284973, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415917, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415918, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0006050', 'pulmonary fibrosis', 0.42857142857142855, 7.528551664415159, 1.7962522489595414, 'UPHENO:0087433', 'abnormal respiratory system morphology'),
(415919, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0005576', 'decreased pulmonary ventilation', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415920, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014275', 'increased respiration', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415921, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010937', 'increased total lung capacity', 0.43902439024390244, 8.526773851447254, 1.9348027524477225, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415922, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415923, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002313', 'abnormal tidal volume', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415924, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001954', 'respiratory distress', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415925, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001952', 'increased airway responsiveness', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415926, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010857', 'pulmonary necrosis', 0.4146341463414634, 7.528551664415159, 1.7668034957409335, 'UPHENO:0087433', 'abnormal respiratory system morphology'),
(415927, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002328', 'abnormal airway resistance', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415928, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002304', 'abnormal total lung capacity', 0.45, 8.526773851447254, 1.9588384908284973, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415929, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010938', 'decreased total lung capacity', 0.43902439024390244, 8.526773851447254, 1.9348027524477225, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415930, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0004780', 'abnormal surfactant secretion', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415931, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0004782', 'abnormal surfactant physiology', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415932, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415933, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010935', 'increased airway resistance', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415934, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010896', 'decreased lung compliance', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415935, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001951', 'abnormal breathing pattern', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415936, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001945', 'bronchoconstriction', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415937, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010992', 'increased surfactant secretion', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415938, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001953', 'respiratory failure', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415939, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0012125', 'decreased bronchoconstrictive response', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415940, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001947', 'abnormal mucociliary clearance', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415941, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010946', 'hyperpnea', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415942, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0001942', 'abnormal lung volume', 0.47368421052631576, 8.526773851447254, 2.009725886821192, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415943, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415944, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0011047', 'increased lung tissue damping', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415945, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0011044', 'increased lung elastance', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415946, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0004881', 'abnormal lung size', 0.42857142857142855, 7.528551664415159, 1.7962522489595414, 'UPHENO:0087433', 'abnormal respiratory system morphology'),
(415947, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002308', 'abnormal residual volume', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415948, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0010752', 'impaired mucociliary clearance', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415949, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0031086', 'wheezing', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415950, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002338', 'abnormal pulmonary ventilation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415951, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002337', 'abnormal whole-body plethysmography', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415952, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002132', 'abnormal respiratory system morphology', 0.41379310344827586, 7.528551664415159, 1.7650106961967769, 'UPHENO:0087433', 'abnormal respiratory system morphology'),
(415953, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002311', 'abnormal inspiratory capacity', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415954, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0011114', 'abnormal airway basal cell differentiation', 0.40476190476190477, 7.528551664415159, 1.7456434091151285, 'UPHENO:0087433', 'abnormal respiratory system morphology'),
(415955, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415956, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002330', 'abnormal bronchial provocation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415957, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0011048', 'decreased lung tissue damping', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415958, 'HP:0034404', 'Fungal hyphae in sputum', 'MP:0002309', 'abnormal vital capacity', 0.46153846153846156, 8.526773851447254, 1.983792853420777, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(415959, 'HP:0012117', 'Hyperalbuminemia', 'MP:0011009', 'increased circulating glutamate dehydrogenase level', 0.5194805194805194, 11.397693902282326, 2.4332858338546197, 'UPHENO:0068533', 'increased level of protein in blood'),
(415960, 'HP:0012117', 'Hyperalbuminemia', 'MP:0004731', 'increased circulating gastrin level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(415961, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008629', 'increased circulating interleukin-9 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415962, 'HP:0012117', 'Hyperalbuminemia', 'MP:0002904', 'increased circulating parathyroid hormone level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(415963, 'HP:0012117', 'Hyperalbuminemia', 'MP:0005610', 'increased circulating antidiuretic hormone level', 0.4025974025974026, 9.97294124817027, 2.0037665140354677, 'UPHENO:0082534', 'increased bodily fluid base level'),
(415964, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008608', 'increased circulating interleukin-13 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415965, 'HP:0012117', 'Hyperalbuminemia', 'MP:0005669', 'increased circulating leptin level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(415966, 'HP:0012117', 'Hyperalbuminemia', 'MP:0005568', 'increased circulating total protein level', 0.4657534246575342, 9.97294124817027, 2.1552103238996625, 'UPHENO:0082534', 'increased bodily fluid base level'),
(415967, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008644', 'increased circulating interleukin-12a level', 0.449438202247191, 11.397693902282326, 2.2633071062508376, 'UPHENO:0068533', 'increased level of protein in blood'),
(415968, 'HP:0012117', 'Hyperalbuminemia', 'MP:0003352', 'increased circulating renin level', 0.5194805194805194, 11.397693902282326, 2.4332858338546197, 'UPHENO:0068533', 'increased level of protein in blood'),
(415969, 'HP:0012117', 'Hyperalbuminemia', 'MP:0005122', 'increased circulating thyroid-stimulating hormone level', 0.4634146341463415, 11.397693902282326, 2.2982293510087612, 'UPHENO:0068533', 'increased level of protein in blood'),
(415970, 'HP:0012117', 'Hyperalbuminemia', 'MP:0005343', 'increased circulating aspartate transaminase level', 0.5194805194805194, 11.397693902282326, 2.4332858338546197, 'UPHENO:0068533', 'increased level of protein in blood'),
(415971, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008626', 'increased circulating interleukin-5 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415972, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008605', 'increased circulating interleukin-7 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415973, 'HP:0012117', 'Hyperalbuminemia', 'MP:0011285', 'increased circulating erythropoietin level', 0.475, 11.397693902282326, 2.3267798786271348, 'UPHENO:0068533', 'increased level of protein in blood'),
(415974, 'HP:0012117', 'Hyperalbuminemia', 'MP:0002712', 'increased circulating glucagon level', 0.4935064935064935, 11.397693902282326, 2.371673660471797, 'UPHENO:0068533', 'increased level of protein in blood'),
(415975, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008614', 'increased circulating interleukin-17 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415976, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008611', 'increased circulating interleukin-15 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415977, 'HP:0012117', 'Hyperalbuminemia', 'MP:0006375', 'increased circulating angiotensinogen level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(415978, 'HP:0012117', 'Hyperalbuminemia', 'MP:0005124', 'increased circulating prolactin level', 0.4578313253012048, 11.397693902282326, 2.2843426416935304, 'UPHENO:0068533', 'increased level of protein in blood'),
(415979, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008647', 'increased circulating interleukin-12b level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415980, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008602', 'increased circulating interleukin-4 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415981, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008635', 'increased circulating interleukin-18 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415982, 'HP:0012117', 'Hyperalbuminemia', 'MP:0009060', 'increased circulating interleukin-21 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415983, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008599', 'increased circulating interleukin-2 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415984, 'HP:0012117', 'Hyperalbuminemia', 'MP:0004702', 'increased circulating insulin-like growth factor I level', 0.48717948717948717, 11.397693902282326, 2.3564215816238554, 'UPHENO:0068533', 'increased level of protein in blood'),
(415985, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008593', 'increased circulating interleukin-10 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415986, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008632', 'increased circulating interleukin-16 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415987, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008575', 'increased circulating interferon-beta level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415988, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008596', 'increased circulating interleukin-6 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415989, 'HP:0012117', 'Hyperalbuminemia', 'MP:0002079', 'increased circulating insulin level', 0.4935064935064935, 11.397693902282326, 2.371673660471797, 'UPHENO:0068533', 'increased level of protein in blood'),
(415990, 'HP:0012117', 'Hyperalbuminemia', 'MP:0002968', 'increased circulating alkaline phosphatase level', 0.5063291139240507, 11.397693902282326, 2.4022872963740545, 'UPHENO:0068533', 'increased level of protein in blood'),
(415991, 'HP:0012117', 'Hyperalbuminemia', 'MP:0005522', 'increased circulating atrial natriuretic factor', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(415992, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008623', 'increased circulating interleukin-3 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415993, 'HP:0012117', 'Hyperalbuminemia', 'MP:0001754', 'increased circulating corticotropin-releasing hormone level', 0.5205479452054794, 11.397693902282326, 2.4357845021499926, 'UPHENO:0068533', 'increased level of protein in blood'),
(415994, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008553', 'increased circulating tumor necrosis factor level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415995, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008641', 'increased circulating interleukin-1 beta level', 0.425531914893617, 11.397693902282326, 2.202290287770779, 'UPHENO:0068533', 'increased level of protein in blood'),
(415996, 'HP:0012117', 'Hyperalbuminemia', 'MP:0011714', 'increased circulating interleukin-8 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415997, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008591', 'increased circulating interleukin-1 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(415998, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008638', 'increased circulating interleukin-1 alpha level', 0.425531914893617, 11.397693902282326, 2.202290287770779, 'UPHENO:0068533', 'increased level of protein in blood'),
(415999, 'HP:0012117', 'Hyperalbuminemia', 'MP:0008577', 'increased circulating interferon-gamma level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(416000, 'HP:0003185', 'Short greater sciatic notch', 'MP:0002115', 'abnormal limb bone morphology', 0.40476190476190477, 6.179485229767373, 1.5815246479421996, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(416001, 'HP:0012549', 'Conjunctival lipoma', 'MP:0031097', 'conjunctival chemosis', 0.4482758620689655, 12.906707549770184, 2.4053618133963246, 'UPHENO:0020997', 'abnormal conjunctiva morphology'),
(416002, 'HP:0012549', 'Conjunctival lipoma', 'MP:0006164', 'ectropion', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(416003, 'HP:0012549', 'Conjunctival lipoma', 'MP:0013402', 'abnormal bulbar conjunctiva morphology', 0.41509433962264153, 12.104646927382092, 2.2415553579349554, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(416004, 'HP:0012549', 'Conjunctival lipoma', 'MP:0002697', 'abnormal eye size', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(416005, 'HP:0012549', 'Conjunctival lipoma', 'MP:0006209', 'calcified intraocular region', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(416006, 'HP:0012549', 'Conjunctival lipoma', 'MP:0012164', 'abnormal conjunctiva goblet cell morphology', 0.4032258064516129, 12.104646927382092, 2.2092772617092864, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(416007, 'HP:0012549', 'Conjunctival lipoma', 'MP:0005176', 'eyelids fail to open', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(416008, 'HP:0012549', 'Conjunctival lipoma', 'MP:0013449', 'abnormal lacrimal lake morphology', 0.40816326530612246, 9.656834392011628, 1.9853375173919245, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(416009, 'HP:0012549', 'Conjunctival lipoma', 'MP:0004481', 'abnormal conjunctival epithelium morphology', 0.41509433962264153, 12.104646927382092, 2.2415553579349554, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(416010, 'HP:0012549', 'Conjunctival lipoma', 'MP:0013461', 'abnormal conjunctiva fornix morphology', 0.41509433962264153, 12.104646927382092, 2.2415553579349554, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(416011, 'HP:0012549', 'Conjunctival lipoma', 'MP:0006166', 'eyelid retraction', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(416012, 'HP:0012549', 'Conjunctival lipoma', 'MP:0003664', 'ocular pterygium', 0.4230769230769231, 12.104646927382092, 2.263006137192152, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(416013, 'HP:0012549', 'Conjunctival lipoma', 'MP:0013744', 'abnormal conjunctival sac morphology', 0.40816326530612246, 12.062826751687464, 2.2189192765377475, 'UPHENO:0087131', 'abnormal conjunctival sac morphology'),
(416014, 'HP:0012549', 'Conjunctival lipoma', 'MP:0001310', 'abnormal conjunctiva morphology', 0.43137254901960786, 12.104646927382092, 2.285084768678654, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(416015, 'HP:0012549', 'Conjunctival lipoma', 'MP:0006191', 'conjunctival deposits', 0.4230769230769231, 12.104646927382092, 2.263006137192152, 'UPHENO:0087576', 'abnormal conjunctiva morphology'),
(416016, 'HP:0012549', 'Conjunctival lipoma', 'MP:0013754', 'abnormal ocular surface morphology', 0.41304347826086957, 9.656834392011628, 1.9971711159201337, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(416017, 'HP:0012549', 'Conjunctival lipoma', 'MP:0030063', 'abnormal face size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(416018, 'HP:0012549', 'Conjunctival lipoma', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.4166666666666667, 9.656834392011628, 2.005911512672359, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(416019, 'HP:0012549', 'Conjunctival lipoma', 'MP:0003671', 'abnormal eyelid aperture', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(416020, 'HP:0012549', 'Conjunctival lipoma', 'MP:0013451', 'nasolacrimal duct obstruction', 0.41818181818181815, 9.656834392011628, 2.0095553149719803, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(416021, 'HP:0012549', 'Conjunctival lipoma', 'MP:0006225', 'ocular rupture', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(416022, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416023, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416024, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416025, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416026, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416027, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416028, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416029, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416030, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416031, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416032, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416033, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416034, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416035, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416036, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416037, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416038, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416039, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416040, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416041, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416042, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416043, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416044, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416045, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416046, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416047, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416048, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416049, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416050, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416051, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416052, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416053, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416054, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416055, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416056, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416057, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416058, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416059, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416060, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416061, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416062, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416063, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416064, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416065, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416066, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416067, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416068, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416069, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416070, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416071, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416072, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416073, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416074, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416075, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416076, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416077, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416078, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416079, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416080, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416081, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416082, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416083, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416084, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416085, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416086, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416087, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416088, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416089, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416090, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416091, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416092, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416093, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416094, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416095, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416096, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416097, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416098, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416099, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416100, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416101, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416102, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416103, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416104, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416105, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416106, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416107, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416108, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416109, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416110, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416111, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416112, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416113, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416114, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416115, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416116, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416117, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416118, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416119, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416120, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416121, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416122, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416123, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416124, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416125, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416126, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416127, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416128, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416129, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416130, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416131, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416132, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416133, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416134, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416135, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416136, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416137, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416138, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416139, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416140, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416141, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416142, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416143, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416144, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416145, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416146, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416147, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416148, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416149, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416150, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416151, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416152, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416153, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416154, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416155, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416156, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416157, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416158, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416159, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416160, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416161, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416162, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416163, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416164, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416165, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416166, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416167, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416168, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416169, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416170, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416171, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416172, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416173, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416174, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416175, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416176, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416177, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416178, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416179, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416180, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416181, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416182, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416183, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416184, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416185, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416186, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416187, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416188, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416189, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416190, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416191, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416192, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416193, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416194, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416195, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416196, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416197, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416198, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416199, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416200, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416201, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416202, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416203, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416204, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416205, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416206, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416207, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416208, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416209, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416210, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416211, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416212, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416213, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416214, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416215, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416216, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416217, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416218, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416219, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416220, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416221, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416222, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416223, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416224, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416225, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416226, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416227, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416228, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416229, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416230, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416231, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416232, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416233, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416234, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416235, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416236, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416237, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416238, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416239, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416240, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416241, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416242, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416243, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416244, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416245, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416246, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416247, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416248, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416249, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416250, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416251, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416252, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416253, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416254, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416255, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416256, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416257, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416258, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416259, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416260, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416261, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416262, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416263, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416264, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416265, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416266, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416267, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416268, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416269, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416270, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416271, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416272, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416273, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416274, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416275, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416276, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416277, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416278, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416279, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416280, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416281, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416282, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416283, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416284, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416285, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416286, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416287, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416288, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416289, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416290, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416291, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416292, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416293, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416294, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416295, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416296, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416297, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416298, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416299, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416300, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416301, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416302, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416303, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416304, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416305, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416306, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416307, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416308, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416309, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416310, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416311, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416312, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416313, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416314, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416315, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416316, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416317, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416318, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416319, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416320, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416321, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416322, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416323, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416324, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416325, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416326, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416327, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416328, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416329, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416330, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416331, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416332, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416333, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416334, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416335, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416336, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416337, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416338, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416339, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416340, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416341, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416342, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416343, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416344, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416345, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416346, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416347, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416348, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416349, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416350, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416351, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416352, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416353, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416354, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416355, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416356, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416357, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416358, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416359, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416360, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416361, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416362, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416363, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416364, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416365, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416366, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416367, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416368, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416369, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416370, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416371, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416372, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416373, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416374, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416375, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416376, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416377, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416378, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416379, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416380, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416381, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416382, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416383, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416384, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416385, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416386, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416387, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416388, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416389, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416390, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416391, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416392, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416393, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416394, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416395, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416396, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416397, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416398, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416399, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416400, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416401, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416402, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416403, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416404, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416405, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416406, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416407, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416408, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416409, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416410, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416411, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416412, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416413, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416414, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416415, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416416, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416417, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416418, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416419, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416420, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416421, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416422, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416423, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416424, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416425, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416426, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416427, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416428, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416429, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416430, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416431, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416432, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416433, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416434, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416435, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416436, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416437, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416438, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416439, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416440, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416441, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416442, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416443, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416444, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416445, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416446, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416447, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416448, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416449, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416450, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416451, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416452, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416453, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416454, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416455, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416456, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416457, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416458, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416459, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416460, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416461, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416462, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416463, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416464, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416465, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416466, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416467, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416468, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416469, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416470, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416471, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416472, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416473, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416474, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416475, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416476, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416477, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416478, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416479, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416480, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416481, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416482, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416483, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416484, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416485, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416486, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416487, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416488, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416489, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416490, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416491, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416492, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416493, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416494, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416495, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416496, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416497, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416498, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416499, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416500, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416501, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416502, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416503, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416504, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416505, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416506, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416507, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416508, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416509, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416510, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416511, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416512, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416513, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416514, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416515, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416516, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416517, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416518, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416519, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416520, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416521, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416522, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416523, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416524, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416525, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416526, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416527, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416528, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416529, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416530, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416531, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416532, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416533, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416534, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416535, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416536, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416537, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416538, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416539, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416540, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416541, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416542, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416543, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416544, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416545, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416546, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416547, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416548, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416549, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416550, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416551, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416552, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416553, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416554, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416555, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416556, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416557, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416558, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416559, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416560, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416561, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416562, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416563, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416564, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416565, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416566, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416567, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416568, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416569, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416570, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416571, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416572, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416573, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416574, 'HP:5000023', 'Anti-Ma1 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(416575, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416576, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0013468', 'chromodacryorrhea', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416577, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006148', 'binocular blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416578, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416579, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0001851', 'eye inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416580, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416581, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006145', 'legal blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416582, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012035', 'abnormal b-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416583, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020861', 'abnormal corneal wound healing', 0.45, 8.795504987450572, 1.98946657281613, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416584, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0013479', 'scleritis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416585, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012145', 'increased a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416586, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012146', 'increased b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416587, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012144', 'decreased b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416588, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020963', 'decreased c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416589, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020977', 'decreased FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416590, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416591, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020220', 'decreased tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416592, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0013478', 'corneal limbitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416593, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0001389', 'abnormal eye movement', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416594, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0004021', 'abnormal rod electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416595, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0003101', 'high myopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416596, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012031', 'abnormal b-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416597, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012149', 'decreased b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416598, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012148', 'decreased a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416599, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0002638', 'abnormal pupillary reflex', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416600, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020860', 'abnormal cornea physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416601, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020962', 'increased c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416602, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006157', 'palsy of the eye', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416603, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012153', 'increased b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416604, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012033', 'abnormal ERG implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416605, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020218', 'abnormal tear production', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416606, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006194', 'keratoconjunctivitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416607, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0010749', 'absent visual evoked potential', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416608, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006153', 'hypermetropia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416609, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012038', 'abnormal a-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416610, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0003665', 'endophthalmitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416611, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020976', 'increased FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416612, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006147', 'monocular blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416613, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012150', 'increased b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416614, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020960', 'increased c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416615, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012154', 'decreased b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416616, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416617, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020959', 'decreased c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416618, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012040', 'abnormal c-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416619, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020439', 'absent b-wave', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416620, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0011832', 'abnormal visual acuity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416621, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020980', 'increased FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416622, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012030', 'abnormal a-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416623, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416624, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0003096', 'increased corneal light-scattering', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416625, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012151', 'increased a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416626, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020958', 'abnormal c-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416627, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012152', 'decreased a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416628, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006152', 'tunnel vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416629, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012032', 'abnormal ERG latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416630, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012034', 'abnormal a-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416631, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416632, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0001313', 'increased incidence of corneal inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416633, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020961', 'abnormal c-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416634, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0005253', 'abnormal eye physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416635, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416636, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0005260', 'ocular hypotension', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416637, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0005258', 'ocular hypertension', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416638, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006190', 'retina ischemia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416639, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416640, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006251', 'eyelid apraxia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416641, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416642, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0001852', 'conjunctivitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416643, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0008144', 'nyctalopia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416644, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006072', 'abnormal retina apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416645, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0013145', 'eye discharge', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416646, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0014157', 'alacrima', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416647, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012143', 'decreased a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416648, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020979', 'decreased FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416649, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416650, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012037', 'abnormal b-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416651, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416652, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012039', 'abnormal b-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416653, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006150', 'double vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416654, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0002001', 'blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416655, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012036', 'abnormal a-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416656, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0005551', 'abnormal eye electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416657, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020219', 'increased tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416658, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006203', 'eye hemorrhage', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416659, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0020974', 'abnormal FO-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416660, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0002090', 'abnormal vision', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416661, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0012147', 'increased a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416662, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0005515', 'uveitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416663, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0003100', 'myopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416664, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0001999', 'photosensitivity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416665, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0005251', 'blepharitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416666, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0001337', 'dry eyes', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416667, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006224', 'oculomotor apraxia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416668, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0010748', 'abnormal visual evoked potential', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416669, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0011275', 'abnormal behavioral response to light', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416670, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0004022', 'abnormal cone electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416671, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0008145', 'hemeralopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416672, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0006149', 'decreased visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416673, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0014132', 'abnormal tear film physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416674, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0003011', 'delayed dark adaptation', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416675, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0031497', 'increased visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416676, 'HP:0031754', 'Medial rectus muscle overaction', 'MP:0005257', 'abnormal intraocular pressure', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(416677, 'HP:0012856', 'Abnormal scrotal rugation', 'MP:0003609', 'small scrotum', 0.40425531914893614, 12.944182255188847, 2.2875214815807445, 'UPHENO:0002981', 'abnormal scrotum'),
(416678, 'HP:0012856', 'Abnormal scrotal rugation', 'MP:0001150', 'enlarged scrotum', 0.40425531914893614, 12.944182255188847, 2.2875214815807445, 'UPHENO:0002981', 'abnormal scrotum'),
(416679, 'HP:0033122', 'Absent P wave', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416680, 'HP:0033122', 'Absent P wave', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416681, 'HP:0033122', 'Absent P wave', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416682, 'HP:0033122', 'Absent P wave', 'MP:0004486', 'decreased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416683, 'HP:0033122', 'Absent P wave', 'MP:0010507', 'shortened RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416684, 'HP:0033122', 'Absent P wave', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416685, 'HP:0033122', 'Absent P wave', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416686, 'HP:0033122', 'Absent P wave', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416687, 'HP:0033122', 'Absent P wave', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416688, 'HP:0033122', 'Absent P wave', 'MP:0031170', 'abnormal vasculature physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416689, 'HP:0033122', 'Absent P wave', 'MP:0011926', 'abnormal heart valve physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416690, 'HP:0033122', 'Absent P wave', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416691, 'HP:0033122', 'Absent P wave', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416692, 'HP:0033122', 'Absent P wave', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416693, 'HP:0033122', 'Absent P wave', 'MP:0031130', 'right-to-left shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416694, 'HP:0033122', 'Absent P wave', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416695, 'HP:0033122', 'Absent P wave', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416696, 'HP:0033122', 'Absent P wave', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416697, 'HP:0033122', 'Absent P wave', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416698, 'HP:0033122', 'Absent P wave', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416699, 'HP:0033122', 'Absent P wave', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416700, 'HP:0033122', 'Absent P wave', 'MP:0010513', 'abnormal ventricular activation time', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416701, 'HP:0033122', 'Absent P wave', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416702, 'HP:0033122', 'Absent P wave', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416703, 'HP:0033122', 'Absent P wave', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416704, 'HP:0033122', 'Absent P wave', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416705, 'HP:0033122', 'Absent P wave', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416706, 'HP:0033122', 'Absent P wave', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416707, 'HP:0033122', 'Absent P wave', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416708, 'HP:0033122', 'Absent P wave', 'MP:0005532', 'abnormal vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416709, 'HP:0033122', 'Absent P wave', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416710, 'HP:0033122', 'Absent P wave', 'MP:0003038', 'decreased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416711, 'HP:0033122', 'Absent P wave', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416712, 'HP:0033122', 'Absent P wave', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416713, 'HP:0033122', 'Absent P wave', 'MP:0004216', 'salt-resistant hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416714, 'HP:0033122', 'Absent P wave', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416715, 'HP:0033122', 'Absent P wave', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416716, 'HP:0033122', 'Absent P wave', 'MP:0010554', 'shortened HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416717, 'HP:0033122', 'Absent P wave', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416718, 'HP:0033122', 'Absent P wave', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416719, 'HP:0033122', 'Absent P wave', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416720, 'HP:0033122', 'Absent P wave', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416721, 'HP:0033122', 'Absent P wave', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416722, 'HP:0033122', 'Absent P wave', 'MP:0010560', 'intraventricular block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416723, 'HP:0033122', 'Absent P wave', 'MP:0004156', 'abnormal QT variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416724, 'HP:0033122', 'Absent P wave', 'MP:0010695', 'abnormal blood pressure regulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416725, 'HP:0033122', 'Absent P wave', 'MP:0010552', 'abnormal HV interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416726, 'HP:0033122', 'Absent P wave', 'MP:0013134', 'poor circulation in autopods', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416727, 'HP:0033122', 'Absent P wave', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416728, 'HP:0033122', 'Absent P wave', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416729, 'HP:0033122', 'Absent P wave', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416730, 'HP:0033122', 'Absent P wave', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416731, 'HP:0033122', 'Absent P wave', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416732, 'HP:0033122', 'Absent P wave', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416733, 'HP:0033122', 'Absent P wave', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416734, 'HP:0033122', 'Absent P wave', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416735, 'HP:0033122', 'Absent P wave', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416736, 'HP:0033122', 'Absent P wave', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416737, 'HP:0033122', 'Absent P wave', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416738, 'HP:0033122', 'Absent P wave', 'MP:0020418', 'increased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416739, 'HP:0033122', 'Absent P wave', 'MP:0003823', 'increased left ventricle developed pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416740, 'HP:0033122', 'Absent P wave', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416741, 'HP:0033122', 'Absent P wave', 'MP:0001598', 'abnormal blood viscosity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416742, 'HP:0033122', 'Absent P wave', 'MP:0010506', 'prolonged RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416743, 'HP:0033122', 'Absent P wave', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416744, 'HP:0033122', 'Absent P wave', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416745, 'HP:0033122', 'Absent P wave', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416746, 'HP:0033122', 'Absent P wave', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416747, 'HP:0033122', 'Absent P wave', 'MP:0002952', 'ventricular cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416748, 'HP:0033122', 'Absent P wave', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416749, 'HP:0033122', 'Absent P wave', 'MP:0010505', 'abnormal T wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416750, 'HP:0033122', 'Absent P wave', 'MP:0001629', 'abnormal heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416751, 'HP:0033122', 'Absent P wave', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416752, 'HP:0033122', 'Absent P wave', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416753, 'HP:0033122', 'Absent P wave', 'MP:0006047', 'aortic valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416754, 'HP:0033122', 'Absent P wave', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416755, 'HP:0033122', 'Absent P wave', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416756, 'HP:0033122', 'Absent P wave', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416757, 'HP:0033122', 'Absent P wave', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416758, 'HP:0033122', 'Absent P wave', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416759, 'HP:0033122', 'Absent P wave', 'MP:0001633', 'poor circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416760, 'HP:0033122', 'Absent P wave', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416761, 'HP:0033122', 'Absent P wave', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416762, 'HP:0033122', 'Absent P wave', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416763, 'HP:0033122', 'Absent P wave', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416764, 'HP:0033122', 'Absent P wave', 'MP:0003900', 'shortened QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416765, 'HP:0033122', 'Absent P wave', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416766, 'HP:0033122', 'Absent P wave', 'MP:0003882', 'abnormal pulse pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416767, 'HP:0033122', 'Absent P wave', 'MP:0006044', 'tricuspid valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416768, 'HP:0033122', 'Absent P wave', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416769, 'HP:0033122', 'Absent P wave', 'MP:0031152', 'subcutaneous hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416770, 'HP:0033122', 'Absent P wave', 'MP:0010636', 'bundle branch block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416771, 'HP:0033122', 'Absent P wave', 'MP:0000231', 'hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416772, 'HP:0033122', 'Absent P wave', 'MP:0010559', 'heart block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416773, 'HP:0033122', 'Absent P wave', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416774, 'HP:0033122', 'Absent P wave', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416775, 'HP:0033122', 'Absent P wave', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416776, 'HP:0033122', 'Absent P wave', 'MP:0011937', 'shortened PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416777, 'HP:0033122', 'Absent P wave', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416778, 'HP:0033122', 'Absent P wave', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416779, 'HP:0033122', 'Absent P wave', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416780, 'HP:0033122', 'Absent P wave', 'MP:0000249', 'abnormal blood vessel physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416781, 'HP:0033122', 'Absent P wave', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416782, 'HP:0033122', 'Absent P wave', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416783, 'HP:0033122', 'Absent P wave', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416784, 'HP:0033122', 'Absent P wave', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416785, 'HP:0033122', 'Absent P wave', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416786, 'HP:0033122', 'Absent P wave', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416787, 'HP:0033122', 'Absent P wave', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416788, 'HP:0033122', 'Absent P wave', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416789, 'HP:0033122', 'Absent P wave', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416790, 'HP:0033122', 'Absent P wave', 'MP:0010392', 'prolonged QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416791, 'HP:0033122', 'Absent P wave', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416792, 'HP:0033122', 'Absent P wave', 'MP:0003896', 'prolonged PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416793, 'HP:0033122', 'Absent P wave', 'MP:0003233', 'prolonged QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416794, 'HP:0033122', 'Absent P wave', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416795, 'HP:0033122', 'Absent P wave', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416796, 'HP:0033122', 'Absent P wave', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416797, 'HP:0033122', 'Absent P wave', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416798, 'HP:0033122', 'Absent P wave', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416799, 'HP:0033122', 'Absent P wave', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416800, 'HP:0033122', 'Absent P wave', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416801, 'HP:0033122', 'Absent P wave', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416802, 'HP:0033122', 'Absent P wave', 'MP:0011952', 'decreased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416803, 'HP:0033122', 'Absent P wave', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416804, 'HP:0033122', 'Absent P wave', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416805, 'HP:0033122', 'Absent P wave', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416806, 'HP:0033122', 'Absent P wave', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416807, 'HP:0033122', 'Absent P wave', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416808, 'HP:0033122', 'Absent P wave', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416809, 'HP:0033122', 'Absent P wave', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416810, 'HP:0033122', 'Absent P wave', 'MP:0001636', 'irregular heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416811, 'HP:0033122', 'Absent P wave', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416812, 'HP:0033122', 'Absent P wave', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416813, 'HP:0033122', 'Absent P wave', 'MP:0010393', 'shortened QRS complex duration', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416814, 'HP:0033122', 'Absent P wave', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416815, 'HP:0033122', 'Absent P wave', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416816, 'HP:0033122', 'Absent P wave', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416817, 'HP:0033122', 'Absent P wave', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416818, 'HP:0033122', 'Absent P wave', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416819, 'HP:0033122', 'Absent P wave', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416820, 'HP:0033122', 'Absent P wave', 'MP:0011953', 'prolonged PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416821, 'HP:0033122', 'Absent P wave', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416822, 'HP:0033122', 'Absent P wave', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416823, 'HP:0033122', 'Absent P wave', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416824, 'HP:0033122', 'Absent P wave', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416825, 'HP:0033122', 'Absent P wave', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416826, 'HP:0033122', 'Absent P wave', 'MP:0009732', 'ventricular premature beat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416827, 'HP:0033122', 'Absent P wave', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416828, 'HP:0033122', 'Absent P wave', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416829, 'HP:0033122', 'Absent P wave', 'MP:0012045', 'increased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416830, 'HP:0033122', 'Absent P wave', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416831, 'HP:0033122', 'Absent P wave', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416832, 'HP:0033122', 'Absent P wave', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416833, 'HP:0033122', 'Absent P wave', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416834, 'HP:0033122', 'Absent P wave', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416835, 'HP:0033122', 'Absent P wave', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416836, 'HP:0033122', 'Absent P wave', 'MP:0003901', 'abnormal PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416837, 'HP:0033122', 'Absent P wave', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416838, 'HP:0033122', 'Absent P wave', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416839, 'HP:0033122', 'Absent P wave', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416840, 'HP:0033122', 'Absent P wave', 'MP:0003037', 'increased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416841, 'HP:0033122', 'Absent P wave', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416842, 'HP:0033122', 'Absent P wave', 'MP:0011918', 'abnormal PQ interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416843, 'HP:0033122', 'Absent P wave', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416844, 'HP:0033122', 'Absent P wave', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416845, 'HP:0033122', 'Absent P wave', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416846, 'HP:0033122', 'Absent P wave', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416847, 'HP:0033122', 'Absent P wave', 'MP:0010756', 'decreased right ventricle peak pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416848, 'HP:0033122', 'Absent P wave', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416849, 'HP:0033122', 'Absent P wave', 'MP:0031192', 'coronary artery spasm', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416850, 'HP:0033122', 'Absent P wave', 'MP:0004011', 'decreased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416851, 'HP:0033122', 'Absent P wave', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416852, 'HP:0033122', 'Absent P wave', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416853, 'HP:0033122', 'Absent P wave', 'MP:0011514', 'skin hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416854, 'HP:0033122', 'Absent P wave', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416855, 'HP:0033122', 'Absent P wave', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416856, 'HP:0033122', 'Absent P wave', 'MP:0005435', 'hemoperitoneum', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416857, 'HP:0033122', 'Absent P wave', 'MP:0020096', 'high mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416858, 'HP:0033122', 'Absent P wave', 'MP:0010394', 'decreased QRS amplitude', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416859, 'HP:0033122', 'Absent P wave', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416860, 'HP:0033122', 'Absent P wave', 'MP:0002842', 'increased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416861, 'HP:0033122', 'Absent P wave', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416862, 'HP:0033122', 'Absent P wave', 'MP:0003820', 'increased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416863, 'HP:0033122', 'Absent P wave', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416864, 'HP:0033122', 'Absent P wave', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416865, 'HP:0033122', 'Absent P wave', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416866, 'HP:0033122', 'Absent P wave', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416867, 'HP:0033122', 'Absent P wave', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416868, 'HP:0033122', 'Absent P wave', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416869, 'HP:0033122', 'Absent P wave', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416870, 'HP:0033122', 'Absent P wave', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416871, 'HP:0033122', 'Absent P wave', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416872, 'HP:0033122', 'Absent P wave', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416873, 'HP:0033122', 'Absent P wave', 'MP:0004086', 'absent heartbeat', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416874, 'HP:0033122', 'Absent P wave', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416875, 'HP:0033122', 'Absent P wave', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416876, 'HP:0033122', 'Absent P wave', 'MP:0031153', 'stomach hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416877, 'HP:0033122', 'Absent P wave', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416878, 'HP:0033122', 'Absent P wave', 'MP:0004071', 'prolonged P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416879, 'HP:0033122', 'Absent P wave', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416880, 'HP:0033122', 'Absent P wave', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416881, 'HP:0033122', 'Absent P wave', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416882, 'HP:0033122', 'Absent P wave', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416883, 'HP:0033122', 'Absent P wave', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416884, 'HP:0033122', 'Absent P wave', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416885, 'HP:0033122', 'Absent P wave', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416886, 'HP:0033122', 'Absent P wave', 'MP:0003929', 'decreased heart rate variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416887, 'HP:0033122', 'Absent P wave', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416888, 'HP:0033122', 'Absent P wave', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416889, 'HP:0033122', 'Absent P wave', 'MP:0006109', 'fibrillation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416890, 'HP:0033122', 'Absent P wave', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416891, 'HP:0033122', 'Absent P wave', 'MP:0010553', 'prolonged HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416892, 'HP:0033122', 'Absent P wave', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416893, 'HP:0033122', 'Absent P wave', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416894, 'HP:0033122', 'Absent P wave', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416895, 'HP:0033122', 'Absent P wave', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416896, 'HP:0033122', 'Absent P wave', 'MP:0006265', 'increased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416897, 'HP:0033122', 'Absent P wave', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416898, 'HP:0033122', 'Absent P wave', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416899, 'HP:0033122', 'Absent P wave', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416900, 'HP:0033122', 'Absent P wave', 'MP:0009275', 'bruising', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416901, 'HP:0033122', 'Absent P wave', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416902, 'HP:0033122', 'Absent P wave', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416903, 'HP:0033122', 'Absent P wave', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416904, 'HP:0033122', 'Absent P wave', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416905, 'HP:0033122', 'Absent P wave', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416906, 'HP:0033122', 'Absent P wave', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416907, 'HP:0033122', 'Absent P wave', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(416908, 'HP:0033122', 'Absent P wave', 'MP:0006114', 'cardiac murmur', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416909, 'HP:0033122', 'Absent P wave', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(416910, 'HP:0033122', 'Absent P wave', 'MP:0006112', 'angina', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
